Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $16.4900 (0.55%) ($16.3600 - $16.6900) on Wed. Jan. 4, 2012. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.45% (three month average) | RSI | 42 | Latest Price | $16.4900(0.55%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | SGEN declines -0.5% a day on average for past five trading days. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) IWM(34%) QQQ(33%) SPY(33%) XLK(29%) XLY(27%) | Factors Impacting SGEN price | SGEN will decline at least -1.725% in a week (0% probabilities). TLT(-11%) SHY(-4%) TIP(-2%) IGOV(-1%) LQD(3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.725% (StdDev 3.45%) | Hourly BBV | 0 () | Intraday Trend | 0.5% | | | |
|
Resistance Level | $16.8 | 5 Day Moving Average | $16.53(-0.24%) | 10 Day Moving Average | $16.64(-0.9%) | 20 Day Moving Average | $16.8(-1.85%) | To recent high | -26% | To recent low | 9.8% | Market Cap | $2.867b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |